Skip to Main Content
877-YALEMDS
SpecialistsFact SheetsDepartmentsClinical TrialsNewsPatient ToolsFor Medical Professionals
877-YALEMDS
ALL KEYWORDS

Marginal Zone Lymphoma

Related Clinical Trials

  • A Randomized Phase 3 Trial of Continuous vs. Intermittent Maintenance Therapy With Zanubrutinib as Upfront Treatment in Older Patients With Mantle Cell Lymphoma

    • Lymphoma
    • A Prospective, Observational, Long-term Follow-up Study for Subjects Who Previously Received Zamtocabtagene Autoleucel in a United States Miltenyi Biomedicine-Sponsored Clinical Study

      • Lymphoma
      • About Us
      • Contact Us
      • Donate
      • Referring Doctors
      • Clinical Keywords

      333 Cedar St.

      New Haven, CT 06510

      • Yale School of Medicine
      • Yale University
      • Terms & Privacy Policies
      • Accessibility at YSM
      • Patient Rights
      • HIPAA at Yale
      • Non-discrimination Statement
      Copyright 2026 Yale Medicine